0001209191-15-055753.txt : 20150623
0001209191-15-055753.hdr.sgml : 20150623
20150623200925
ACCESSION NUMBER: 0001209191-15-055753
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150619
FILED AS OF DATE: 20150623
DATE AS OF CHANGE: 20150623
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AMICUS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001178879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 200422823
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
BUSINESS PHONE: (609) 662-2000
MAIL ADDRESS:
STREET 1: 1 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Dilone Enrique
CENTRAL INDEX KEY: 0001510394
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-33497
FILM NUMBER: 15948040
MAIL ADDRESS:
STREET 1: 6 CEDAR BROOK DRIVE
CITY: CRANBURY
STATE: NJ
ZIP: 08512
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-06-19
0
0001178879
AMICUS THERAPEUTICS INC
FOLD
0001510394
Dilone Enrique
1 CEDAR BROOK DRIVE
CRANBURY
NJ
08512
0
1
0
0
SVP, Technical Operations
Common stock
2015-06-19
4
M
0
14045
13.2627
A
44733
D
Common stock
2015-06-19
4
S
0
14045
13.2627
D
30688
D
Stock Options (right to buy)
4.16
2015-06-19
4
M
0
3250
0.00
D
2013-11-01
2019-11-16
Common Stock
3250
6500
D
Stock Options (right to buy)
4.38
2015-06-19
4
M
0
1896
0.00
D
2013-06-04
2022-06-04
Common stock
1896
31208
D
Stock Options (right to buy)
3.53
2015-06-19
4
M
0
2624
0.00
D
2014-01-28
2023-01-28
Common stock
2624
22752
D
Stock Options (right to buy)
2.52
2015-06-19
4
M
0
3463
0.00
D
2014-06-18
2023-06-18
Common stock
3463
28074
D
Stock Options (right to buy)
2.45
2015-06-19
4
M
0
2812
0.00
D
2015-01-03
2024-01-03
Common stock
2812
39376
D
The exercise of stock options and subsequent sales of common stock were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 17, 2014.
This price is the weighted average purchase price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares purchased at each separate price.
This price is the weighted average sale price for the transactions reported on this line. The prices for the transactions reported on this line range from $13.16 to $13.33. The reporting person undertakes to provide, upon request, by the staff of the Securities and Exchange Commission, the issuer, or a security holder of the issuer, full information regarding the number of shares sold at each separate price.
/s/ Enrique Dilone
2015-06-23